Kalyani Chemicals And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.18 M
- Company Age 45 Year, 1 Month
- Last Filing with ROC 31 Mar 2019
- Revenue Growth %
- Ebitda
- Net Worth -1.81%
- Total Assets -0.34%
About Kalyani Chemicals And Pharmaceuticals
Kalyani Chemicals And Pharmaceuticals Pvt Ltd (KCAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 December 1979 and has a history of 45 years and one month. Its registered office is in Nadia, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.18 M, as per Ministry of Corporate Affairs (MCA) records.
Abdus Satter, Amenul Hoque, and Sahin Sahanaz serve as directors at the Company.
Company Details
-
Location
Nadia, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U15205WB1979PTC032433
-
Company No.
032433
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Dec 1979
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Kalyani Chemicals And Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abdus Satter
|
Director | 11-Jun-2013 | Current |
|
Amenul Hoque
|
Director | 11-Jun-2013 | Current |
|
Sahin Sahanaz
|
Director | 30-May-2019 | Current |
Financial Performance of Kalyani Chemicals And Pharmaceuticals.
Kalyani Chemicals And Pharmaceuticals Pvt Ltd, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 1.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kalyani Chemicals And Pharmaceuticals?
In 2019, Kalyani Chemicals And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kalyani Chemicals And Pharmaceuticals?
Unlock and access historical data on people associated with Kalyani Chemicals And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kalyani Chemicals And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kalyani Chemicals And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
